Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase I trial to evaluate the safety, tolerability and immunogenicity of high dose live recombinant canarypox ALVAC-HIV vaccine (vCP1452) in healthy, in HIV-1 uninfected adult participants
Description
HVTN 039 is a Phase I clinical trial to evaluate the safety and immunogenicity of high dose ALVAC-HIV (vCP1452).
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.